(6Z,9Z,28Z,31Z)-Heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate, 98%

Name: (6Z,9Z,28Z,31Z)-Heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate, 98% | 1224606-06-7
Brand: J&K Chemical
SKU: JK938874_100_MG
Price: 315.5 USD
Availability: OutOfStock

Cat. No JK938874_100_MG

Vendor: J&K Chemical

Product Information

Product Name

(6Z,9Z,28Z,31Z)-Heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate, 98%

Brand Name

J&K

Product Number

938874

CAS

1224606-06-7

Molecular Formula

C43H79NO2

Molecular Weight

642.09

Certificate of Analysis (COA)

COA not found

General Information

Synonyms

D-Lin-MC3-DMA

PubChem CID

49785164

IUPAC Name

(6Z,9Z,28Z,31Z)-heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate

InChI Key

NRLNQCOGCKAESA-KWXKLSQISA-N

SMILES

CCCCC/C=C\C/C=C\CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC/C=C\C/C=C\CCCCC

Properties

Density

0.89

Boiling Point

670.2±43.0

Flash Point

Safety Information

Storage Condition

Store at 2-8℃

References Data Source From Pubchem

Rational design of rigid mRNA folding architecture to enhance intracellular processing and protein production

Publication Name: Nature Nanotechnology

Publication Date: 2026-03

DOI: 10.1038/s41565-025-02114-9

A disease-severity-responsive nanoparticle enables potent ghrelin messenger RNA therapy in osteoarthritis

Publication Name: Nature Nanotechnology

Publication Date: 2026-01-14

DOI: 10.1038/s41565-025-02101-0

Lipid nanoparticle encapsulated TLR3 agonist adjuvant elicits potent T cell immunity against cancer and viruses

Publication Name: npj Vaccines

Publication Date: 2025-12-23

DOI: 10.1038/s41541-025-01349-w

Chemical strategies for brain delivery of genomic therapy

Publication Name: Nature reviews. Chemistry

Publication Date: 2025-11-25

DOI: 10.1038/s41570-025-00770-y

Emerging roles of RNA-binding protein hnRNPM in alternative splicing regulation and UTMD mediated sh-hnRNPM/CMBs suppress the proliferation of colorectal cancer

Publication Name: Oncogene

Publication Date: 2025-10-19

DOI: 10.1038/s41388-025-03599-3

(6Z,9Z,28Z,31Z)-Heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate, 98%

Product Information

General Information

Properties

Safety Information

References Data Source From Pubchem

Rational design of rigid mRNA folding architecture to enhance intracellular processing and protein production

A disease-severity-responsive nanoparticle enables potent ghrelin messenger RNA therapy in osteoarthritis

Lipid nanoparticle encapsulated TLR3 agonist adjuvant elicits potent T cell immunity against cancer and viruses

Chemical strategies for brain delivery of genomic therapy

Emerging roles of RNA-binding protein hnRNPM in alternative splicing regulation and UTMD mediated sh-hnRNPM/CMBs suppress the proliferation of colorectal cancer